Calif. High Court Won't Rehear Cipro Pay-For-Delay Ruling More
The California Supreme Court declined Wednesday to revisit its May ruling reviving drug buyers' claims that Bayer Corp. illegally paid generic manufacturers $400 million to delay launching copycat versions of blockbuster...To view the full article, register now.
Already a subscriber? Click here to view full article